All Posts

Cardiovascular diseases remain the leading cause of mortality worldwide, with myocardial infarction (MI) representing one of the main drivers of progression toward heart failure. The abrupt and irreversible loss of cardiomyocytes, combined with vascular disruption, triggers a cascade of events that culminates in fibrotic scar formation, permanently impairing the contractile function of the myocardium. Despite significant advances in pharmacological therapies, assistive devic

How Hepatic Devices Can Replace Animal Models and Bridge the Path to Future Transplants

How to Move Beyond the Hype and Truly Reach the Patient

Anyone who works at a bioprinting bench knows the frustration: you have the perfect cell type, a promising hydrogel, but the bioprinter clogs, the scaffold collapses, or cell viability plummets after 24 hours. For years, biofabrication has been an art driven by “trial and error.”